Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) SHH
6.37
-0.11(-1.70%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
6.37
-0.11(-1.70%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1385
First IPO Date
July 02, 2014
| Name | Title | Pay | Year Born |
| Hong Li Lin | GM & Chairman | 0 | 1993 |
| Hong Sheng Xu | Deputy General Manager | 0 | 1982 |
| Mingxiong Huang | Board Secretary & Director | 0 | 1993 |
| Xiusong Lin | Deputy GM, Financial Director, Director & Accounting Supervisor | 0 | 1969 |
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antipyretic and analgesic, antibacterial anti-inflammatory, endocrine, auxiliary, cardiovascular, detoxification, diuretic row stone, gynecology, and infusion categories. It offers its products in injections, oral solutions, eye drops, tablets, capsules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 1978 and is based in Pinghu, China.